MVK-33196-94100
4 vaccinations
1 coded response
30 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 113 / NY
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-17
Registered in v-safe
-
2021-01-17
Dose 1 — Moderna
- 2021-01-17
- 2021-01-19
- 2021-01-21
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-01-24
- 2021-02-02
- 2021-02-09
-
2021-02-14
Dose 2 — Moderna
- 2021-02-14
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-02-19
- 2021-02-21
- 2021-02-28
- 2021-03-09
- 2021-03-14
- 2021-03-21
- 2021-03-30
- 2021-05-16
- 2021-08-17
-
2021-12-14
Dose 3 — Moderna
- 2022-02-16
-
2022-09-23
Dose 4 — Moderna
-
2022-10-13
Survey response — day 14, dose 4MedDRA: COVID-19, Unevaluable event — Feeling: GoodFree text: Cell dysplasia and a covid reinfection may 18, 2022MedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-21
- 2022-10-29
- 2022-11-04
- 2022-12-23
- 2023-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-17 | Moderna | |
| 2 | 2021-02-14 | Moderna | |
| 3 | 2021-12-14 | Moderna | No |
| 4 | 2022-09-23 | Moderna | No |
Free text
Release 12 — day 14, dose 4
Symptoms: Cell dysplasia and a covid reinfection may 18, 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release